SEC Form 4/A · accession 0001209191-16-112628
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Aram S. Adourian
Officer — SVP & Chief Scientific Officer
Period of report
Aug 15, 2015
Accepted (ET)
Apr 4, 2016 · 8:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 15, 2015 | F | 6,233 | $0.83 | D | 43,226 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Relates to shares withheld for payment of tax liability upon vesting of restricted stock units ("RSUs"). The RSUs were granted on October 16, 2014 and vested as to 50% on August 15, 2015 resulting in a net issuance to the holder of 13,492 shares.
- F2Represents 23,501 shares of common stock and 19,725 RSUs.
Remarks
This amendment to Form 4 is being filed solely to correct the number of (i) securities listed in column 5 of Table I and (ii) shares of common stock listed in footnote (2) in the original Form 4 reporting this transaction, filed on August 19, 2015. This amendment to Form 4 amends, restates and supersedes, in its entirety, the Form 4 filed on August 19, 2015.